Norwegian version of this page

BiO and NCMM organized under the Faculty of Medicine

From 1 April, the Biotechnology Centre of Oslo (BiO) and the Centre for Molecular Medicine Norway (NCMM), both UiO centres, will be organized under the Faculty of Medicine on a par with the faculty’s three institutes.

Four people around a table

From left: Head of Section of Administrative Services in the faculty administration Anita Robøle, head of administration at NCMM Elisa Bjørgo, head of administration at BiO Ingrid Kjelsvik and the Centre Director for BiO and NCMM Kjetil Tasken. Photo: UiO

The Biotechnology Centre of Oslo (BiO) and the Centre for Molecular Medicine Norway (NCMM) are a breeding ground for young, talented researchers.

The centres seek to attract the best young researchers from around the world and allow them to establish their own research groups. The aim is to give young, promising research talents the opportunity to pursue their own research interests and independently develop research questions in a stimulating, competitive environment.

Anita Robøle is responsible at the faculty for the organizational changeover of our two new centres, BiO and NCMM.

New organization creates new impetus

With the new organization, the faculty's new centres BiO and NCMM remain key elements of the life sciences focus at UiO. The new focus on life sciences at UiO aims to take a more interdisciplinary, overarching and strategically broader approach.

Centre Director Kjetil Tasken is looking forward to the new centres being added to our large faculty. This gives the centres:

• access to operational facilities and capacity they did not have before;

• additional support for funding, administrative support and, not least, support for communications activities;

• an equal footing with the institutes in the organizational structure.

New focus on life sciences at UiO

Head of Section of Administrative Services in the faculty administration, Anita Robøle, is responsible for helping the centres adapt to the faculty and implement all necessary measures in connection with the reorganization.

Both the BiO and NCMM were previously included in UiO’s first life science initiative, Molecular Life science - MLS UiO.

MLS UiO encompassed research into biological processes and phenomena where the analysis of underlying biomolecules constitutes a central element. This research primarily covered the generic disciplines of biochemistry/chemistry, molecular biology, genetics, cellular biology and bioinformatics.

Centre for Molecular Medicine Norway (NCMM)

The Centre for Molecular Medicine Norway was established in 2008 as a national centre for molecular medicine and translational research. The centre is the Norwegian node in the Nordic EMBL (European Molecular Biology Laboratory) partnership in molecular medicine, which also includes the equivalent national centres in Finland, Sweden and Denmark, plus EMBL.

The centre is funded by UiO, the Research Council of Norway and the South-Eastern Norway Regional Health Authority.

NCMM studies disease mechanisms in cancer, cardiovascular and CNS-related diseases and immunological diseases. NCMM aims to capitalize on functional genomics research in order to develop individually tailored applications. Discovering new diagnostic methods and drug targets are also focus areas.

The centre has established six new research groups in its first five-year period, with young, talented and internationally-sourced group leaders who were recruited in line with EMBL’s model and criteria.

Biotechnology Centre of Oslo (BiO)

The Biotechnology Centre of Oslo is an international centre for research in molecular biology, biotechnology and functional genomics. The centre is owned by UiO and puts special focus on research in disease mechanisms.

In recent years, BiO has also focused on developing technology platforms, and offers services in molecular interaction analysis and chemical biology.

The centre is well on its way to establishing a new research group in chemical neuroscience using zebrafish as a model system, and will also eventually strengthen its expertise in chemistry and life sciences through the recruitment of two new research groups.

By Elisa Bjørgo, Ingrid Kjelsvik and Silje M. Kile Rosseland
Published June 8, 2016 2:12 PM - Last modified Mar. 12, 2021 11:08 AM